| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |